REG - PureTech Health PLC - Transaction in Own Shares
26/10/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231026:nRSZ3169Ra&default-theme=true
RNS Number : 3169R PureTech Health PLC 26 October 2023
26 October 2023
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 25 October 2023
Number of ordinary shares purchased: 38,361
Highest price paid per share: 169.40p
Lowest price paid per share: 163.40p
Volume weighted average price paid per share: 166.20p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 15,789,236 ordinary
shares in treasury and has 273,678,923 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 273,678,923 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
25/10/2023 14:01:04 227 169.4 XLON 00375333087TRLO0.1.1
25/10/2023 14:01:04 13 169.4 XLON 00375333088TRLO0.1.1
25/10/2023 14:01:04 239 169.4 XLON 00375333089TRLO0.1.1
25/10/2023 14:01:04 2107 169.4 XLON 00375333090TRLO0.1.1
25/10/2023 14:01:30 180 169.4 XLON 00375333166TRLO0.1.1
25/10/2023 14:02:48 907 166.6 XLON 00375333349TRLO0.1.1
25/10/2023 14:02:48 572 166.6 XLON 00375333348TRLO0.1.1
25/10/2023 14:02:53 228 168.2 XLON 00375333355TRLO0.1.1
25/10/2023 14:02:58 176 168.8 XLON 00375333366TRLO0.1.1
25/10/2023 14:02:58 210 168.8 XLON 00375333365TRLO0.1.1
25/10/2023 14:03:01 615 168.6 XLON 00375333388TRLO0.1.1
25/10/2023 14:03:01 503 168.8 XLON 00375333389TRLO0.1.1
25/10/2023 14:04:36 509 168.8 XLON 00375333666TRLO0.1.1
25/10/2023 14:07:34 998 168.8 XLON 00375334120TRLO0.1.1
25/10/2023 14:07:38 499 168.8 XLON 00375334137TRLO0.1.1
25/10/2023 14:07:44 499 168.8 XLON 00375334174TRLO0.1.1
25/10/2023 14:07:49 235 168.8 XLON 00375334180TRLO0.1.1
25/10/2023 14:07:49 499 168.8 XLON 00375334181TRLO0.1.1
25/10/2023 14:07:55 26 168.6 XLON 00375334212TRLO0.1.1
25/10/2023 14:07:55 499 168.6 XLON 00375334213TRLO0.1.1
25/10/2023 14:08:39 499 168.6 XLON 00375334332TRLO0.1.1
25/10/2023 14:08:41 564 168.6 XLON 00375334367TRLO0.1.1
25/10/2023 14:08:41 499 168.6 XLON 00375334368TRLO0.1.1
25/10/2023 14:14:44 498 169 XLON 00375335145TRLO0.1.1
25/10/2023 14:32:51 197 168.8 AQXE 00375341505TRLO0.1.1
25/10/2023 14:32:53 730 168.6 XLON 00375341525TRLO0.1.1
25/10/2023 14:32:54 30 168.6 XLON 00375341537TRLO0.1.1
25/10/2023 14:32:54 610 168.6 XLON 00375341539TRLO0.1.1
25/10/2023 14:32:56 109 168.6 XLON 00375341549TRLO0.1.1
25/10/2023 14:32:59 168 168.2 CHIX 00375341564TRLO0.1.1
25/10/2023 14:33:05 270 168.2 CHIX 00375341607TRLO0.1.1
25/10/2023 14:33:07 22 168.2 CHIX 00375341613TRLO0.1.1
25/10/2023 14:33:26 94 167.8 TRQX 00375341845TRLO0.1.1
25/10/2023 14:33:26 413 167.4 BATE 00375341846TRLO0.1.1
25/10/2023 14:34:19 1722 166.8 XLON 00375342302TRLO0.1.1
25/10/2023 14:35:59 558 166.8 XLON 00375343418TRLO0.1.1
25/10/2023 14:37:03 22 165.4 XLON 00375343925TRLO0.1.1
25/10/2023 14:37:05 11 166 AQXE 00375343956TRLO0.1.1
25/10/2023 14:38:06 471 165.4 XLON 00375344425TRLO0.1.1
25/10/2023 14:38:06 1479 165.4 XLON 00375344426TRLO0.1.1
25/10/2023 14:38:11 974 165.4 AQXE 00375344457TRLO0.1.1
25/10/2023 14:46:29 197 165.4 AQXE 00375350573TRLO0.1.1
25/10/2023 14:46:30 32 165.6 TRQX 00375350586TRLO0.1.1
25/10/2023 14:46:34 32 165.6 BATE 00375350635TRLO0.1.1
25/10/2023 14:47:50 500 165.6 XLON 00375352074TRLO0.1.1
25/10/2023 14:52:07 460 165.2 CHIX 00375354226TRLO0.1.1
25/10/2023 14:52:07 267 165.2 XLON 00375354227TRLO0.1.1
25/10/2023 14:52:07 50 165.2 XLON 00375354228TRLO0.1.1
25/10/2023 14:52:07 1162 165.2 XLON 00375354229TRLO0.1.1
25/10/2023 14:52:07 196 165 BATE 00375354230TRLO0.1.1
25/10/2023 14:52:07 191 165 BATE 00375354231TRLO0.1.1
25/10/2023 14:52:07 262 164.8 XLON 00375354233TRLO0.1.1
25/10/2023 14:52:07 26 165 BATE 00375354232TRLO0.1.1
25/10/2023 14:52:07 8 164.8 XLON 00375354234TRLO0.1.1
25/10/2023 14:52:07 223 164.8 XLON 00375354235TRLO0.1.1
25/10/2023 14:52:30 507 165.2 XLON 00375354372TRLO0.1.1
25/10/2023 14:52:30 498 165.2 XLON 00375354373TRLO0.1.1
25/10/2023 15:00:54 186 165 XLON 00375357706TRLO0.1.1
25/10/2023 15:01:10 180 165 XLON 00375357854TRLO0.1.1
25/10/2023 15:01:10 188 165 TRQX 00375357855TRLO0.1.1
25/10/2023 15:01:10 650 165 XLON 00375357856TRLO0.1.1
25/10/2023 15:01:10 463 165 XLON 00375357857TRLO0.1.1
25/10/2023 15:10:05 94 164.8 TRQX 00375360743TRLO0.1.1
25/10/2023 15:11:05 545 164.6 XLON 00375360996TRLO0.1.1
25/10/2023 15:11:05 441 164.6 XLON 00375360997TRLO0.1.1
25/10/2023 15:11:54 380 164.4 CHIX 00375361143TRLO0.1.1
25/10/2023 15:11:54 1000 164.4 CHIX 00375361142TRLO0.1.1
25/10/2023 15:11:54 460 164.4 CHIX 00375361144TRLO0.1.1
25/10/2023 15:11:54 493 164.4 XLON 00375361145TRLO0.1.1
25/10/2023 15:11:54 413 164.2 BATE 00375361154TRLO0.1.1
25/10/2023 15:11:54 1324 164.2 XLON 00375361156TRLO0.1.1
25/10/2023 15:11:54 155 164.2 XLON 00375361155TRLO0.1.1
25/10/2023 15:11:54 197 164 AQXE 00375361157TRLO0.1.1
25/10/2023 15:12:39 250 164.8 TRQX 00375361377TRLO0.1.1
25/10/2023 15:24:42 628 164 BATE 00375365152TRLO0.1.1
25/10/2023 15:27:55 232 164.2 XLON 00375366134TRLO0.1.1
25/10/2023 15:28:46 110 164.4 XLON 00375366324TRLO0.1.1
25/10/2023 15:37:01 1578 164 XLON 00375368628TRLO0.1.1
25/10/2023 15:43:17 302 163.4 CHIX 00375370662TRLO0.1.1
25/10/2023 15:46:51 94 164.2 TRQX 00375372210TRLO0.1.1
25/10/2023 16:04:58 10 163.4 CHIX 00375380483TRLO0.1.1
25/10/2023 16:09:20 8 164.2 TRQX 00375382696TRLO0.1.1
25/10/2023 16:10:45 86 164.2 TRQX 00375383351TRLO0.1.1
25/10/2023 16:12:38 325 163.8 XLON 00375384239TRLO0.1.1
25/10/2023 16:12:38 1071 163.8 XLON 00375384238TRLO0.1.1
25/10/2023 16:12:38 83 163.8 XLON 00375384240TRLO0.1.1
25/10/2023 16:13:42 10 163.6 CHIX 00375385006TRLO0.1.1
25/10/2023 16:14:46 10 163.6 CHIX 00375385530TRLO0.1.1
25/10/2023 16:15:36 2 163.6 CHIX 00375386206TRLO0.1.1
25/10/2023 16:20:29 10 163.6 BATE 00375389330TRLO0.1.1
25/10/2023 16:20:42 105 163.6 CHIX 00375389461TRLO0.1.1
25/10/2023 16:23:09 195 163.6 BATE 00375391196TRLO0.1.1
25/10/2023 16:23:09 11 163.6 BATE 00375391197TRLO0.1.1
25/10/2023 16:23:16 197 164 AQXE 00375391240TRLO0.1.1
25/10/2023 16:25:14 117 163.6 BATE 00375392492TRLO0.1.1
25/10/2023 16:25:14 80 163.6 BATE 00375392491TRLO0.1.1
25/10/2023 16:25:14 216 163.6 BATE 00375392493TRLO0.1.1
25/10/2023 16:25:39 140 163.4 XLON 00375392713TRLO0.1.1
25/10/2023 16:25:45 600 163.4 XLON 00375392758TRLO0.1.1
25/10/2023 16:25:45 72 163.4 XLON 00375392759TRLO0.1.1
25/10/2023 16:29:00 6 163.8 AQXE 00375394760TRLO0.1.1
25/10/2023 16:29:38 8 164.2 TRQX 00375395076TRLO0.1.1
25/10/2023 16:29:41 86 164.2 TRQX 00375395121TRLO0.1.1
25/10/2023 16:29:55 258 163.6 CHIX 00375395306TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFIDIRLEFIVRecent news on Puretech Health
See all newsREG - PureTech Health PLC - Total Voting Rights
AnnouncementREG - PureTech Health PLC - Final Results
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementRCS - PureTech Health PLC - PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
AnnouncementRCS - PureTech Health PLC - FDA Grants PRTC's LYT-200 Fast Track Designation
Announcement